-
Product Insights
NewLikelihood of Approval Analysis for Open-Angle Glaucoma
Overview How likely is it that the drugs in Open-Angle Glaucoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Open-Angle Glaucoma Overview Open-angle glaucoma is a chronic eye condition characterized by...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sepetaprost in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sepetaprost in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sepetaprost in Open-Angle Glaucoma Drug Details: Sepetaprost (DE-126) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Bimatoprost Grenod in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bimatoprost Grenod in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bimatoprost Grenod in Open-Angle Glaucoma Drug Details: Bimatoprost grenod (NCX-470) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGN-193408 SR in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGN-193408 SR in Open-Angle Glaucoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGN-193408 SR in Open-Angle Glaucoma Drug Details: AGN-193408 SR is...
-
Product Insights
Open-Angle Glaucoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Open-Angle Glaucoma - Drugs In Development, 2023’, provides an overview of the Open-Angle Glaucoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ILution Travoprost in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ILution Travoprost in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ILution Travoprost in Open-Angle Glaucoma Drug Details: Travoprost is under development...
-
Sector Analysis
Prophylaxis Angles and Cups Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Prophylaxis Angles and Cups Market Report Overview The prophylaxis angles and cups market size was valued at $346.1 million in 2023 and will grow at a CAGR of more than 1% during 2023 and 2033. The Prophylaxis Angles and Cups industry will witness strong growth during the forecast period owing to the rising popularity of cosmetic dentistry. Prophylaxis angles is a dental instrument usually attached to a dental handpiece intended for specific cleaning and scaling of teeth. Prophylaxis cups are...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBI-100 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBI-100 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBI-100 in Open-Angle Glaucoma Drug Details: NB-1111 is under development for the...
-
Product Insights
North Angle Solar Project
North Angle Solar Project is a solar PV project located in England, United Kingdom. The project is owned by Cambridgeshire County Council. The project is at the permitting stage. Empower your strategies with our North Angle Solar Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PA-5108 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PA-5108 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PA-5108 in Open-Angle Glaucoma Drug Details: PA-5108 is under development for the...